🧬Neuroscience & CNS
Companies developing treatments for neurological and psychiatric disorders including Alzheimer's, Parkinson's, and depression.
Market Cap$237.9B
1D+0.74%
Companies657
Public Cos98
SECTOR MARKET CAP
$237.9B+51775.0%ALL
TOP COMPANIES
| # | Company | Country | Valuation | Ticker |
|---|---|---|---|---|
| 1 |  | Belgium | $52.5B | UCB.VI |
| 2 |  | Japan | $37.1B | 4578.T |
| 3 |  | United States | $28.4B | BIIB |
| 4 |  | United States | $15.1B | NBIX |
| 5 |  | Hong Kong | $15.0B | RGC |
| 6 |  | United States | $11.3B | AXSM |
| 7 |  | United States | $9.5B | CYTK |
| 8 |  | United States | $9.3B | PRAX |
| 9 |  | Japan | $8.4B | 4523.T |
| 10 |  | Denmark | $6.7B | HLUN-B.CO |
| 11 |  | Canada | $5.5B | XENE |
| 12 | | Belgium | $4.0B | UCB |
| 13 |  | Sweden | $3.1B | BIOA-B.ST |
| 14 |  | United States | $2.1B | TRVI |
| 15 |  | United States | $1.9B | TSHA |
| 16 |  | United States | $1.9B | RAPP |
| 17 |  | United States | $1.8B | HRMY |
| 18 |  | United States | $1.7B | AMLX |
| 19 |  | Netherlands | $1.5B | QURE |
| 20 |  | United States | $1.5B | BHVN |